Second Annual Michigan Alzheimer’s Disease Core Center Research Symposium, Beyond Amyloid: Call For Abstracts
The MADCC is hosting the second annual MADCC research symposium, Beyond Amyloid! The keynote speakers will be Dr. Charles DeCarli, MD, Director of the Alzheimer’s Disease Center, UC Davis presenting on “Vascular Risk and Aβ Interaction: Reducing Cortical Thickness in AD Vulnerable Brain Regions” and Dr. Caleb Finch, PhD–ARCO/William F. Kieschnick Professor Neurobiology of Aging, USC presenting[…]
Michigan Alzheimer’s Disease Center’s Isadore & Margaret Mezey Junior Investigator Travel Award Competition
The Michigan Alzheimer’s Disease Center is pleased to announce the launch of the Isadore & Margaret Mezey Junior Investigator Travel Award competition. The Michigan Alzheimer’s Disease Center is committed to promoting the advancement of dementia research skills through the provision of training resources. This award will pay for travel expenses associated with participation in national or international conferences focusing[…]
We are pleased to announce that the Associate Director of the MADC, Dr. Bruno Giordani, has been chosen as the senior director of The Mary A. Rackham Institute beginning this year. Dr. Giordani is also a Professor of Psychiatry, Neurology, and Psychology at the University of Michigan and Adjunct Professor of Nursing. He is currently[…]
A new clinical trials consortium funded by the National Institutes of Health is expected to accelerate and expand studies for therapies in Alzheimer’s disease and related dementias. The infrastructure of 35 sites across the United States — called the Alzheimer’s Clinical Trial Consortium (ACTC) — will address the timeframe, complexity, and expense of the recruitment[…]
The MADC bi-annual print newsletter “Mind Matters” is now out. Read about our center’s progress and changes that have occurred this past year including a new grant for our wellness initiative that will help to spread wellness resources for caregivers across Michigan, the successful launch of a new program for individuals with dementia based off of[…]
Submit an abstract to present at the Alzheimer’s Association International Conference (AAIC), the world’s premier dementia forum. Share your work with world-renowned basic and clinical researchers, early career investigators, clinicians and the care research community as part of the global meeting to advance dementia research. Submit your work today and help shape the 2018 conference[…]
We are pleased to announce the launch of the Michigan Alzheimer’s Disease Center Pilot Project Program 2018-2019 competition. Click on the link below to view more information. Thank you! Internal Submission Deadline: Monday, January 15, 2018 Award Cycle: 2018-2019 Discipline/Subject Area: Neurology/dementia Funding Available: 35,000.00 Description: The Michigan Alzheimer’s Disease Center (MADC) announces the availability[…]
The Michigan Alzheimer’s Disease Core Center (MADCC) is pleased to announce openings in its MADCC Mentoring Program for Junior Investigators (MMPJI). The MMPJI has 2 aims. One, providing junior investigators entering the field of dementia research with a broad education about contemporary dementia research. Two, providing junior investigators with mentoring by experienced investigators in developing[…]
Faculty & Investigators
Partnering for a Purpose
Michigan State University
Wayne State University
Michigan Center for Urban African American Aging Research
NIH Institute on Aging
Udall Center of Excellence for Parkinson’s Disease Research
VA Ann Arbor Healthcare System
Claude D Pepper Older Americans Independence Centers
University of Michigan Key Links
U-M Department of Neurology
U-M School of Public Health
U-M Department of Psychiatry
U-M School of Social Work
By 2025, the number of people age 65 and older with Alzheimer’s dementia will increase by 35%.
32% of people age 85 and older have Alzheimer’s dementia.
Approximately 40% of family caregivers of people with dementia suffer from depression.
By 2025, total Medicaid costs for people in Michigan age 65 and older living with Alzheimer’s or other dementias will increase by almost 30%.